Investor Relations

SEC Filings

Document Details

Form
Filing Date
Nov 25, 2024
Document Date
Nov 21, 2024
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
BioXcel Therapeutics
Issuer
BioXcel Therapeutics, Inc.